Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2021 | Story Rulanzen Martin

As in previous years, the Department of South African Sign Language and Deaf Studies (SASL) – a pioneering force within deaf studies – will embark on a broader campaign to create much-needed awareness of the deaf. 

This year’s #UFSDeafAwarenesscampaign aims to inform and contribute to an inclusive society, not only among the UFS community, but also among the public. The department, together with the Centre for Universal Access and Disability Support, provides exceptional support to the 16 deaf and hard of hearing students at the UFS. 

Jani de Lange, Lecturer in Deaf Studies at the UFS, says the deaf forms part of the diverse South African community – “however, there are still many misconceptions about the deaf world. Therefore, deaf awareness plays an important role in facilitating a bridge between hearing and deaf people”.  

Awareness, duty, and social responsibility collide 

Many of the staff in the department considers themselves part of the deaf community. “They play a major role in educating others through our academic programmes, as well as continuous workshops and short learning programmes,” says De Lange. She continues, saying that by celebrating Deaf Awareness Month, “we are reminded of our role and responsibility towards the deaf.” 

The department also has a long-standing relationship with Mimosa Mall in Bloemfontein, with conversational students displaying their final group projects in the centre of the shopping mall.  Mimosa is also a partner in school-based projects, such as the Bartimea School for the Deaf and Blind in Thaba Nchu. “Every year, the department, together with our student association, Signals, and all interested Sign Language students, visits Bartimea, where we host a variety of activities with the children and also help the school with small maintenance projects. In 2019 – the last time we were able to visit the school – we repainted parts of the Foundation Phase’s playground,” De Lange says.

“We hope that the public will take the time to read about deafness, Sign Language, and the deaf community to understand the exciting traditions of the culture.”  The end goal is to encourage a greater understanding that ‘you do not need hearing to listen’

Getting the community involved 

To get people involved in the campaign, the department invites UFS staff to participate in a competition where they can learn how to introduce themselves in SASL. The department is also planning an informal training session for staff and students on 7 September 2021. 


The Department of SASL and Deaf Studies also presents a FREE Introduction to SASL short learning programme. 

  Click here for more information 


 #UFSDeafAwarenessMonth #DeafAwareness #DeafCommunity


                     


News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept